Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study
Gespeichert in:
| Veröffentlicht in: | International journal of urology 2022-05, Vol.29 (5), p.478-479 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 479 |
|---|---|
| container_issue | 5 |
| container_start_page | 478 |
| container_title | International journal of urology |
| container_volume | 29 |
| creator | Shiota, Masaki |
| description | |
| doi_str_mv | 10.1111/iju.14864 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2640321639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2658946055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3374-7604e390fa1e90868bd4678afc28f2ed5309d10f900f5d59f83e275ba9835b1c3</originalsourceid><addsrcrecordid>eNp1kc1u1DAQgC0EokvhwAsgS1zgkNZ_-TG3arVAUSUu9Bx5nbHqVRIH29lqb30EHqfP0ydhtikckPDF4_E3n8YeQt5ydsZxnfvdfMZVU6lnZMWVEoVgSjwnK6a5LhpeixPyKqUdY1wK3rwkJ7IUuuacrcj9pvM5RG96ug7DAGOmOdCNc2AzDY7Ok4sBkzYMWz-a7MNI8w1EMx3oEtKwx2Pf0zTHvd-jCMsmJNGV6K3PN3SAbFLGlKUWg_ioebj7lWBMPvs90CmGIwB4P1qIn-gFHeYeC1ACkUbICEzY0xFOee4Or8kLZ_oEb572U3L9efNj_bW4-v7lcn1xVVgpa1XUFVMgNXOGg2ZN1Ww7VdWNcVY0TkBXSqY7zpxmzJVdqV0jQdTl1uhGlltu5Sn5sHixxZ8zpNwOPlnoezNCmFMrKsXwVyupEX3_D7oLcxyxO6TKRquKlSVSHxfK4pNSBNdO0Q8mHlrO2uM4Wxxn-zhOZN89GeftAN1f8s_8EDhfgFvfw-H_pvby2_Wi_A0lpa8t</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2658946055</pqid></control><display><type>article</type><title>Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Shiota, Masaki</creator><creatorcontrib>Shiota, Masaki</creatorcontrib><identifier>ISSN: 0919-8172</identifier><identifier>ISSN: 1442-2042</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/iju.14864</identifier><identifier>PMID: 35297110</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Androgen Antagonists - therapeutic use ; Castration ; Humans ; Male ; Metastases ; Prostate cancer ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - surgery ; Prostatic Neoplasms, Castration-Resistant - drug therapy ; Prostatic Neoplasms, Castration-Resistant - pathology ; Retrospective Studies</subject><ispartof>International journal of urology, 2022-05, Vol.29 (5), p.478-479</ispartof><rights>2022 The Japanese Urological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3374-7604e390fa1e90868bd4678afc28f2ed5309d10f900f5d59f83e275ba9835b1c3</cites><orcidid>0000-0002-3306-4858</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fiju.14864$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fiju.14864$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35297110$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shiota, Masaki</creatorcontrib><title>Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><subject>Androgen Antagonists - therapeutic use</subject><subject>Castration</subject><subject>Humans</subject><subject>Male</subject><subject>Metastases</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Prostatic Neoplasms, Castration-Resistant - drug therapy</subject><subject>Prostatic Neoplasms, Castration-Resistant - pathology</subject><subject>Retrospective Studies</subject><issn>0919-8172</issn><issn>1442-2042</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAQgC0EokvhwAsgS1zgkNZ_-TG3arVAUSUu9Bx5nbHqVRIH29lqb30EHqfP0ydhtikckPDF4_E3n8YeQt5ydsZxnfvdfMZVU6lnZMWVEoVgSjwnK6a5LhpeixPyKqUdY1wK3rwkJ7IUuuacrcj9pvM5RG96ug7DAGOmOdCNc2AzDY7Ok4sBkzYMWz-a7MNI8w1EMx3oEtKwx2Pf0zTHvd-jCMsmJNGV6K3PN3SAbFLGlKUWg_ioebj7lWBMPvs90CmGIwB4P1qIn-gFHeYeC1ACkUbICEzY0xFOee4Or8kLZ_oEb572U3L9efNj_bW4-v7lcn1xVVgpa1XUFVMgNXOGg2ZN1Ww7VdWNcVY0TkBXSqY7zpxmzJVdqV0jQdTl1uhGlltu5Sn5sHixxZ8zpNwOPlnoezNCmFMrKsXwVyupEX3_D7oLcxyxO6TKRquKlSVSHxfK4pNSBNdO0Q8mHlrO2uM4Wxxn-zhOZN89GeftAN1f8s_8EDhfgFvfw-H_pvby2_Wi_A0lpa8t</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Shiota, Masaki</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3306-4858</orcidid></search><sort><creationdate>202205</creationdate><title>Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study</title><author>Shiota, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3374-7604e390fa1e90868bd4678afc28f2ed5309d10f900f5d59f83e275ba9835b1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Androgen Antagonists - therapeutic use</topic><topic>Castration</topic><topic>Humans</topic><topic>Male</topic><topic>Metastases</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Prostatic Neoplasms, Castration-Resistant - drug therapy</topic><topic>Prostatic Neoplasms, Castration-Resistant - pathology</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shiota, Masaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shiota, Masaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2022-05</date><risdate>2022</risdate><volume>29</volume><issue>5</issue><spage>478</spage><epage>479</epage><pages>478-479</pages><issn>0919-8172</issn><issn>1442-2042</issn><eissn>1442-2042</eissn><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35297110</pmid><doi>10.1111/iju.14864</doi><tpages>479</tpages><orcidid>https://orcid.org/0000-0002-3306-4858</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0919-8172 |
| ispartof | International journal of urology, 2022-05, Vol.29 (5), p.478-479 |
| issn | 0919-8172 1442-2042 1442-2042 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2640321639 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Androgen Antagonists - therapeutic use Castration Humans Male Metastases Prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - surgery Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - pathology Retrospective Studies |
| title | Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A21%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20Comment%20to%20Effect%20of%20upfront%20combination%20therapy%20on%20the%20overall%20survival%20of%20patients%20with%20metastatic%20castration%E2%80%90sensitive%20prostate%20cancer:%20A%20multicenter%20retrospective%20study&rft.jtitle=International%20journal%20of%20urology&rft.au=Shiota,%20Masaki&rft.date=2022-05&rft.volume=29&rft.issue=5&rft.spage=478&rft.epage=479&rft.pages=478-479&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/iju.14864&rft_dat=%3Cproquest_cross%3E2658946055%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2658946055&rft_id=info:pmid/35297110&rfr_iscdi=true |